HLS Therapeutics Inc. Investor Presentation November 2023

HLS Therapeutics is a North American commercially-focused pharmaceutical company with operations in neuroscience and cardiovascular therapeutic areas. The company reported 2022 revenue of $61.5M USD and adjusted EBITDA of $23.8M USD, with headquarters in Toronto and operations across North America.